Latest It Services News

Resonance Health reports record $14.9M cash receipts over 12 months and completes cost-cutting measures while advancing two major pharma clinical trials on schedule.

Pact Group Holdings has announced its intention to voluntarily delist from the ASX, citing a concentrated shareholder base, low liquidity, and high regulatory costs. Shareholder approval will be sought at an extraordinary general meeting in June 2025.

Harmoney Corp upgrades its FY25 cash NPAT guidance to $5.5 million, driven by strong loan book growth and improved margins, while announcing a strategic 5% on-market share buy-back.

Way2VAT Ltd reported a robust 54% increase in Q1 FY25 revenue to A$1.05 million, driven by new client onboarding and higher VAT claim volumes, alongside strategic cost reductions and fresh credit facilities.

Emyria Limited reports sustained clinical success in its PTSD program, launches a new treatment-resistant depression therapy, and opens a second Empax Centre to meet growing demand. The company is progressing funding discussions with health insurers and government bodies to support expansion.

H&G High Conviction Limited has completed a major asset divestment, distributing over 63 million Hancock & Gore shares to its shareholders and signaling potential delisting and strategic shifts ahead.

Harmoney has raised its FY25 cash NPAT guidance to $5.5 million and announced an on-market share buy-back, setting the stage for accelerated loan book growth and improved returns in FY26.

Far East Gold Ltd has advanced its exploration efforts in Indonesia with imminent drilling at Idenburg and Trenggalek, backed by a $4.78 million strategic investment from Xingye Gold, increasing their stake to nearly 20%.

Odyssey Gold has initiated a Technical Study to explore mining and processing strategies for its Tuckanarra Project, leveraging a new partnership with Monument Murchison Ltd to potentially process ore at the nearby Burnakura Mill.

Core Lithium Ltd progresses its Finniss Lithium Project Restart Study, securing full ownership of site infrastructure and reporting promising gold exploration results at Shoobridge.

Lumos Diagnostics reported a 21% quarter-on-quarter revenue increase in Q3 FY25, driven by strong product sales and expanded development agreements. The company also secured Medicare coverage in key US regions and advanced its pivotal FebriDx CLIA waiver study with FDA submission expected by year-end.

FINEOS Corporation Holdings PLC reported a robust first quarter for FY25, with cash balances soaring to €35.4 million and customer receipts up 40% year-on-year, underpinned by successful platform deployments and a healthy sales pipeline in North America.